Legend Biotech - American Depositary Shares (LEGN) closed at $21.63 on October 30, 2026, down 3.0% from the previous close, on volume of 2,062,722 shares (30-day average 1,987,973).
Data as of October 30, 2026.
30-Oct-2026
TipRanks (Thu, 29-Oct 9:15 AM ET)
Legend Biotech to Host Investor Conference Call on Third Quarter 2026 Results
Globe Newswire (Tue, 27-Oct 8:00 AM ET)
Gabelli To Host 8th Annual Healthcare Symposium
Globe Newswire (Mon, 26-Oct 8:00 AM ET)
Globe Newswire (Thu, 15-Oct 8:00 AM ET)
Globe Newswire (Thu, 1-Oct 9:00 AM ET)
Globe Newswire (Fri, 25-Sep 7:00 AM ET)
Legend Biotech Appoints Ingrid Zhang as Chief Executive Officer
Globe Newswire (Tue, 15-Sep 8:00 AM ET)
Globe Newswire (Thu, 10-Sep 8:00 AM ET)
Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference
Globe Newswire (Tue, 1-Sep 8:00 AM ET)
Legend Biotech Reports Second Quarter 2026 Results and Recent Highlights
Globe Newswire (Tue, 11-Aug 7:00 AM ET)
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
Legend Biotech - American Depositary Shares trades on the NASDAQ stock market under the symbol LEGN.
As of October 30, 2026, LEGN stock price declined to $21.63 with 2,062,722 million shares trading.
LEGN has a beta of 1.35, meaning it tends to be more sensitive to market movements. LEGN has a correlation of 0.05 to the broad based SPY ETF.
LEGN has a market cap of $4.21 billion. This is considered a Mid Cap stock.
Last quarter Legend Biotech - American Depositary Shares reported $388 million in Revenue and $.16 earnings per share. This beat revenue expectation by $34 million and missed earnings estimates by -$.09.
In the last 3 years, LEGN traded as high as $70.13 and as low as $16.24.
The top ETF exchange traded funds that LEGN belongs to (by Net Assets): IBB, IEMG, PBE, CANC, EEM.
LEGN has underperformed the market in the last year with a return of -32.9%, while SPY returned +12.3%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in LEGN shares. However, LEGN has outperformed the market in the last 3 month and 2 week periods, returning +13.5% and +17.0%, while SPY returned +2.1% and -1.0%, respectively. This indicates LEGN has been having a stronger performance recently.
LEGN support price is $21.45 and resistance is $23.15 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LEGN shares will trade within this expected range on the day.
